159 related articles for article (PubMed ID: 29268009)
1. Reduction Responsive Nanovesicles Derived from Novel α-Tocopheryl-Lipoic Acid Conjugates for Efficacious Drug Delivery to Sensitive and Drug Resistant Cancer Cells.
Maiti B; Kumar K; Moitra P; Kondaiah P; Bhattacharya S
Bioconjug Chem; 2018 Feb; 29(2):255-266. PubMed ID: 29268009
[TBL] [Abstract][Full Text] [Related]
2. Reduction-responsive disassemblable core-cross-linked micelles based on poly(ethylene glycol)-b-poly(N-2-hydroxypropyl methacrylamide)-lipoic acid conjugates for triggered intracellular anticancer drug release.
Wei R; Cheng L; Zheng M; Cheng R; Meng F; Deng C; Zhong Z
Biomacromolecules; 2012 Aug; 13(8):2429-38. PubMed ID: 22746534
[TBL] [Abstract][Full Text] [Related]
3. Lipoic acid-derived cross-linked liposomes for reduction-responsive delivery of anticancer drug.
Ling L; Ismail M; Du Y; Yao C; Li X
Int J Pharm; 2019 Apr; 560():246-260. PubMed ID: 30769133
[TBL] [Abstract][Full Text] [Related]
4. Synthesis and Characterization of Dual-Sensitive Fluorescent Nanogels for Enhancing Drug Delivery and Tracking Intracellular Drug Delivery.
Wu SY; Debele TA; Kao YC; Tsai HC
Int J Mol Sci; 2017 May; 18(5):. PubMed ID: 28534813
[TBL] [Abstract][Full Text] [Related]
5. Intracellular release of doxorubicin from core-crosslinked polypeptide micelles triggered by both pH and reduction conditions.
Wu L; Zou Y; Deng C; Cheng R; Meng F; Zhong Z
Biomaterials; 2013 Jul; 34(21):5262-72. PubMed ID: 23570719
[TBL] [Abstract][Full Text] [Related]
6. Redox and pH-responsive degradable micelles for dually activated intracellular anticancer drug release.
Chen W; Zhong P; Meng F; Cheng R; Deng C; Feijen J; Zhong Z
J Control Release; 2013 Aug; 169(3):171-9. PubMed ID: 23306022
[TBL] [Abstract][Full Text] [Related]
7. Novel reduction-sensitive micellar nanoparticles assembled from Rituximab-doxorubicin conjugates as smart and intuitive drug delivery systems for the treatment of non-Hodgkin's lymphoma.
Yin H; Meng T; Shu L; Mao M; Zhou L; Chen H; Song D
Chem Biol Drug Des; 2017 Nov; 90(5):892-899. PubMed ID: 28440948
[TBL] [Abstract][Full Text] [Related]
8. Polyacrylic acid modified upconversion nanoparticles for simultaneous pH-triggered drug delivery and release imaging.
Jia X; Yin J; He D; He X; Wang K; Chen M; Li Y
J Biomed Nanotechnol; 2013 Dec; 9(12):2063-72. PubMed ID: 24266261
[TBL] [Abstract][Full Text] [Related]
9. Enzyme-induced and tumor-targeted drug delivery system based on multifunctional mesoporous silica nanoparticles.
Cheng YJ; Luo GF; Zhu JY; Xu XD; Zeng X; Cheng DB; Li YM; Wu Y; Zhang XZ; Zhuo RX; He F
ACS Appl Mater Interfaces; 2015 May; 7(17):9078-87. PubMed ID: 25893819
[TBL] [Abstract][Full Text] [Related]
10. Redox-responsive degradable prodrug nanogels for intracellular drug delivery by crosslinking of amine-functionalized poly(N-vinylpyrrolidone) copolymers.
Peng H; Huang X; Melle A; Karperien M; Pich A
J Colloid Interface Sci; 2019 Mar; 540():612-622. PubMed ID: 30690386
[TBL] [Abstract][Full Text] [Related]
11. Ligand-directed reduction-sensitive shell-sheddable biodegradable micelles actively deliver doxorubicin into the nuclei of target cancer cells.
Zhong Y; Yang W; Sun H; Cheng R; Meng F; Deng C; Zhong Z
Biomacromolecules; 2013 Oct; 14(10):3723-30. PubMed ID: 23998942
[TBL] [Abstract][Full Text] [Related]
12. Imaging-Guided Drug Release from Glutathione-Responsive Supramolecular Porphysome Nanovesicles.
Xu XD; Zhao L; Qu Q; Wang JG; Shi H; Zhao Y
ACS Appl Mater Interfaces; 2015 Aug; 7(31):17371-80. PubMed ID: 26186168
[TBL] [Abstract][Full Text] [Related]
13. Redox/pH dual stimuli-responsive biodegradable nanohydrogels with varying responses to dithiothreitol and glutathione for controlled drug release.
Pan YJ; Chen YY; Wang DR; Wei C; Guo J; Lu DR; Chu CC; Wang CC
Biomaterials; 2012 Sep; 33(27):6570-9. PubMed ID: 22704845
[TBL] [Abstract][Full Text] [Related]
14. Efficient Delivery of DOX to Nuclei of Hepatic Carcinoma Cells in the Subcutaneous Tumor Model Using pH-Sensitive Pullulan-DOX Conjugates.
Li H; Cui Y; Sui J; Bian S; Sun Y; Liang J; Fan Y; Zhang X
ACS Appl Mater Interfaces; 2015 Jul; 7(29):15855-65. PubMed ID: 26140410
[TBL] [Abstract][Full Text] [Related]
15. Evaluation of cytotoxicity profile and intracellular localisation of doxorubicin-loaded chitosan nanoparticles.
Souto GD; Farhane Z; Casey A; Efeoglu E; McIntyre J; Byrne HJ
Anal Bioanal Chem; 2016 Aug; 408(20):5443-55. PubMed ID: 27225177
[TBL] [Abstract][Full Text] [Related]
16. Thermal and pH responsive polymer-tethered multifunctional magnetic nanoparticles for targeted delivery of anticancer drug.
Sahoo B; Devi KS; Banerjee R; Maiti TK; Pramanik P; Dhara D
ACS Appl Mater Interfaces; 2013 May; 5(9):3884-93. PubMed ID: 23551195
[TBL] [Abstract][Full Text] [Related]
17. Redox-responsive mesoporous silica nanoparticles: a physiologically sensitive codelivery vehicle for siRNA and doxorubicin.
Ma X; Teh C; Zhang Q; Borah P; Choong C; Korzh V; Zhao Y
Antioxid Redox Signal; 2014 Aug; 21(5):707-22. PubMed ID: 23931896
[TBL] [Abstract][Full Text] [Related]
18. Comparative studies of polyethylenimine-doxorubicin conjugates with pH-sensitive and pH-insensitive linkers.
Dong DW; Tong SW; Qi XR
J Biomed Mater Res A; 2013 May; 101(5):1336-44. PubMed ID: 23065848
[TBL] [Abstract][Full Text] [Related]
19. Doxorubicin-loaded glycyrrhetinic acid modified recombinant human serum albumin nanoparticles for targeting liver tumor chemotherapy.
Qi WW; Yu HY; Guo H; Lou J; Wang ZM; Liu P; Sapin-Minet A; Maincent P; Hong XC; Hu XM; Xiao YL
Mol Pharm; 2015 Mar; 12(3):675-83. PubMed ID: 25584860
[TBL] [Abstract][Full Text] [Related]
20. Synthesis of pH-responsive chitosan nanocapsules for the controlled delivery of doxorubicin.
Chen CK; Wang Q; Jones CH; Yu Y; Zhang H; Law WC; Lai CK; Zeng Q; Prasad PN; Pfeifer BA; Cheng C
Langmuir; 2014 Apr; 30(14):4111-9. PubMed ID: 24665861
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
